Heather Bosley Email & Phone Number

Indiana, United States

2023 Hypernova Award winnerDrives physician and patient identification and market developmentProactively builds effective working relationships with internal/external stakeholdersCollaborates with key accounts and physicians to drive patient identification through market development and physician educationClosely collaborates with stakeholders across commercial, compliance, legal, market access, and patient care centers to help ensure access at site of care

Indiana

2018 MATT Award (Meet at the Top) - rewarded to those in the top 1% of sales internationallyEducating cardiologists and pulmonologists on treating patients with pulmonary arterial hypertension (PAH). I excel in partnering with healthcare professionals in either treating or referring their patients for treatment, specialty pharmacy synergy, and in developing partnerships with accounts for future projects.Seeks out and sponsors support groupsWorks collaboratively with multiple stakeholdersAccounts encompass all of Indiana

Sales presentations, consult, support and educate physicians, nurses, cath labs, pharmacists, pharmacy techs, case managers, social workers, MAs, staff, billing specialists on Brilinta and Farxiga (cardiovascular and endocrinology markets) Business planning, product strategyInnovative by seeking out all possible diabetic patient touch points along the patient journey in the hospital to identify the best opportunities and to troubleshoot to ensure prescription protectionLead sales training teleconferences for our team as the team was new to therapeutic areaMentor and support representatives whom were struggling in new technical consultative sellingCollaborate with internal customers to ensure proper expense reportingCustomer service, follows upAccount Management

Create excellent sales experience with Seroquel XR/Seroquel and Pristiq, focusing primarily on community health centers, inpatient behavioral units, private practice psychiatry, and internal medicine practicesCoordinate promotional efforts across all therapeutic areas with internal and external customers of AstraZeneca and verify compliance and referrals Launch new pain management product, Movantik, into a new market Launch new product, Seroquel XR, to market for schizophrenia, bipolar mania, bipolar depression and adjunct major depressive disorderEducate and service entire office staff on reimbursement issues with new productsManage technical and educational presentations for physicians, case managers, nursing staff, administrative staff, pharmacists and pharmacy techniciansForecast, implement and report effective, detailed, and targeted business plan quarterlyDeliver solutions and policies for reimbursement, patient assistance programs, and patient education safety Mentor primary care representatives on consultative selling with customersManaged team for 2 different 6-month time frames while team was without a manager

Indianapolis, Indiana Area

Sales calls of Seroquel and Nexium to internists, family practice physicians, and gastroenterologistsCollaborate with partners in the Indianapolis territory Facilitate education programs, lunch appointments, and staff meetings Support physicians in care of their patients Distribute and manage product inventory controlMS Office specialistPromoted from this position to CNS Specialty Care Representative

Central Indiana

Launched Crestor to cardiologists, cath labs, and internistsProduct sales of Crestor, Toprol-XL, Sular, Zestril, Zestoretic, and Accolate to cardiologists, cath lab staff, internists, and family practice physicians Promoted Nolvadex to obstetricians/gynecologists and internistsCompliance championProblem solver for the Central/Southern Indiana territoryPerformed daily pharmacy calls to monitor prescribing trendsManage product inventory control

Southern Indiana

Promoted Zestril, Zestoretic, and Sular to internists and family practice physicians Managed Southern part of Indiana territoryManage product inventory controlOffered a full time position with AstraZeneca Pharmaceuticals at the end of this contract